GlaxoSmithKline Faces Allegations in China

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline Plc, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Is Tesla’s Downgrade an Opportunity for Investors
03:42 - IDDS Group co-founder and CEO Max Zanan and Jefferies Analyst Dan Dolev discuss the Tesla being downgraded with Emily Chang on “Bloomberg West.” (Source: Bloomberg)
  • Ukraine’s Jaresko: I'm Optimistic About Russia Bond Talks
  • Dell to Offer Data Storage Giant EMC $33 Per Share
  • Uber Closing In On 2014 Hack Suspect